{"id":"W2176736150","doi":"10.1016/j.bbmt.2015.10.005","title":"Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors","year":2015,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute; H. Lundbeck A/S; Juno Therapeutics; Incyte; CTI Biopharma; Agios Pharmaceuticals; Novavax; Karyopharm Therapeutics; MorphoSys; Celgene; Alexion Pharmaceuticals; Amgen; Ariad Pharmaceuticals; Teva Pharmaceutical Industries; Gilead Sciences; Sanofi; Spectrum Pharmaceuticals; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Ruxolitinib; Myelofibrosis; Internal medicine; Adverse effect; Transplantation; International Prognostic Scoring System; Cytopenia; Hematopoietic stem cell transplantation; Gastroenterology; Calcineurin; Confidence interval; Oncology; Bone marrow; Myelodysplastic syndromes","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008724114,0.0001754979,0.0004143592,0.0001605689,0.0000208511,0.000002982007,0.00003050463,0.00009467966,0.000005598707],"category_scores_gemma":[0.000005373508,0.0001147369,0.00003083142,0.0001264895,0.00007368922,0.00005382946,0.000002911028,0.00005109093,0.000001003634],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001092499,"about_ca_system_score_gemma":0.00006049925,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007911114,"about_ca_topic_score_gemma":0.0001713941,"domain_scores_codex":[0.9990863,0.00005559957,0.0003136467,0.0002433807,0.0001548897,0.0001462012],"domain_scores_gemma":[0.9994856,0.00006354372,0.000115473,0.00009796638,0.0001213556,0.0001160434],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002887826,0.0007993499,0.9790344,0.0004775911,0.0001098848,0.00002259959,0.002582368,0.00001984281,0.01303285,0.00003500601,0.000002271777,0.0009960429],"study_design_scores_gemma":[0.01070494,0.005688578,0.7801731,0.0002435339,0.0005342398,0.0000155163,0.0001179749,3.489062e-7,0.2024037,0.00001043413,0.000002643821,0.0001050102],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985584,0.0002021703,0.00008588978,0.000167487,0.00002812796,0.0007603127,0.0001129547,0.00001014603,0.00007451438],"genre_scores_gemma":[0.9969968,0.000188692,0.00236753,0.00005696063,0.000007290838,0.00006564504,0.0002951834,0.00001246577,0.000009417206],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1988613,"threshold_uncertainty_score":0.4678836,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008503955860677247,"score_gpt":0.2224208301226908,"score_spread":0.2139168742620136,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}